Investigators demonstrated that phospholipase D3 (PLD3) and miR-6796 are co-expressed in breast cancer. PLD3 could bind with CDK1 and inhibit its expression, leading to mitotic arrest and inhibiting breast cancer proliferation.
[Cell Death & Disease]